Compare Panin Financial Tbk. (PNLF) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Panin Financial Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Panin Financial Tbk. trades at Rp222 (market cap 7.17T, 18.83M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Panin Financial Tbk. is far larger — about 68.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PNLF | SCPI | |
|---|---|---|
Market Cap | 7.17T | 104.4B |
Volume | 18.83M | — |
Lot | 188.33K | — |
Turnover | 4.19B | — |
Average Price | 222.41 | — |
Value | 4.19B | — |
Indicative Equilibrium Price | 222 | — |
Indicative Equilibrium Volume | 2.21K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Panin Financial Tbk.
PT Panin Financial Tbk (the Company) was established in Jakarta under the name PT Asuransi Jiwa Panin Putra on July 19, 1974 based on Notarial Deed No.192 which was changed by Notarial Deed No. 226 dated February 27, 1975, both notarized by Ridwan Suselo, S.H., notary in Jakarta. Starting , and the company is one of the Panin Group`s member. In 1994, the company joint venture with the Australian Mutual Provident Society.
Read more on PNLF →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
